{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:20:49Z","timestamp":1793665249671,"version":"4.5.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,8,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Radiologically defined sarcopenia (RS), defined as a lack of skeletal muscle mass (SMM) measured on cross-sectional CT or MR imaging, is increasingly recognized as a significant prognostic determinant in head and neck cancer (HNC). A systematic literature search of Embase and Medline was performed to identify studies investigating the impact of pre-treatment sarcopenia on the prognosis of HNC patients. All available survival and other treatment-related outcomes were extracted and analyzed in a multi-level meta-analysis. Sixty-three studies comprising data from 14,804 patients were analyzed. The overall estimated log OR was 0.644 (95% CI\u2009=\u20090.505\u20130.783,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), suggesting that patients with RS have a higher risk of worse outcomes. In 43 studies there was a significant effect of sarcopenia on survival, with a log OR of 0.808 (95% CI\u2009=\u20090.509\u20131.107,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). In 15 studies RS was shown to be a risk factor for treatment-related complications (log OR\u2009=\u20090.669, 95% CI\u2009=\u20090.441\u20130.897,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). We conclude that pre-treatment radiologically defined sarcopenia is a robust prognostic and predictive factor in HNC patients and is associated with worse survival and increased risk of treatment-related complications.\n                  <\/jats:p>","DOI":"10.1038\/s41416-025-03049-7","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T17:39:23Z","timestamp":1748885963000},"page":"131-143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The predictive and prognostic role of radiologically defined sarcopenia in head and neck cancer: a systematic review and multi-level meta-analysis"],"prefix":"10.1038","volume":"133","author":[{"given":"Hugo C.","family":"van Heusden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje A.","family":"van Beers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk W. M. A.","family":"Schaeffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin E.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-5814","authenticated-orcid":false,"given":"Remco","family":"de Bree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"3049_CR1","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41415-022-5166-x","volume":"233","author":"M Gormley","year":"2022","unstructured":"Gormley M, Creaney G, Schache A, Ingarfield K, Conway DI. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br Dent J. 2022;233:780\u20136. https:\/\/doi.org\/10.1038\/s41415-022-5166-x.","journal-title":"Br Dent J"},{"key":"3049_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1056\/nejmra1715715","volume":"382","author":"LQM Chow","year":"2020","unstructured":"Chow LQM. Head and neck cancer. N Engl J Med. 2020;382:60\u201372. https:\/\/doi.org\/10.1056\/nejmra1715715.","journal-title":"N Engl J Med"},{"key":"3049_CR3","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.joms.2013.04.028","volume":"71","author":"A Alshadwi","year":"2013","unstructured":"Alshadwi A, Nadershah M, Carlson ER, Young LS, Burke PA, Daley BJ. Nutritional considerations for head and neck cancer patients: a review of the literature. J Oral Maxillofac Surg. 2013;71:1853\u201360. https:\/\/doi.org\/10.1016\/j.joms.2013.04.028.","journal-title":"J Oral Maxillofac Surg"},{"key":"3049_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jcsm.12443","volume":"10","author":"AT Zwart","year":"2019","unstructured":"Zwart AT, Van Der Hoorn A, Van Ooijen PMA, Steenbakkers RJHM, De Bock GH, Halmos GB. CT\u2010measured skeletal muscle mass used to assess frailty in patients with head and neck cancer. J Cachexia Sarcopenia Muscle. 2019;10:1060\u20139. https:\/\/doi.org\/10.1002\/jcsm.12443.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3049_CR5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/sj.bjc.6605578","volume":"102","author":"M Pressoir","year":"2010","unstructured":"Pressoir M, Desn\u00e9 S, Berchery D, Rossignol G, Poiree B, Meslier M, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102:966\u201371. https:\/\/doi.org\/10.1038\/sj.bjc.6605578.","journal-title":"Br J Cancer"},{"key":"3049_CR6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1001\/archoto.2009.174","volume":"135","author":"DJ Givens","year":"2009","unstructured":"Givens DJ, Karnell LH, Gupta AK, Clamon GH, Pagedar NA, Chang KE, et al. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer. Arch Otolaryngol Neck Surg. 2009;135:1209. https:\/\/doi.org\/10.1001\/archoto.2009.174.","journal-title":"Arch Otolaryngol Neck Surg"},{"key":"3049_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169.","journal-title":"Age Ageing"},{"key":"3049_CR8","doi-asserted-by":"publisher","first-page":"e13343","DOI":"10.1111\/ecc.13343","volume":"30","author":"PB Silva","year":"2021","unstructured":"Silva PB, Ramos GHA, Petterle RR, Borba VZC. Sarcopenia as an early complication of patients with head and neck cancer with dysphagia. Eur J Cancer Care. 2021;30:e13343. https:\/\/doi.org\/10.1111\/ecc.13343.","journal-title":"Eur J Cancer Care"},{"key":"3049_CR9","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","volume":"97","author":"W Shen","year":"2004","unstructured":"Shen W, Punyanitya M, Wang Z, Gallagher D, St.-Onge MP, Albu J, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. 2004;97:2333\u20138. https:\/\/doi.org\/10.1152\/japplphysiol.00744.2004.","journal-title":"J Appl Physiol"},{"key":"3049_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395. https:\/\/doi.org\/10.1016\/s1470-2045(10)70218-7.","journal-title":"Lancet Oncol"},{"key":"3049_CR11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3758\/s13428-012-0261-6","volume":"45","author":"W Van Den Noortgate","year":"2013","unstructured":"Van Den Noortgate W, L\u00f3pez-L\u00f3pez JA, Mar\u00edn-Mart\u00ednez F, S\u00e1nchez-Meca J. Three-level meta-analysis of dependent effect sizes. Behav Res Methods. 2013;45:576\u201394. https:\/\/doi.org\/10.3758\/s13428-012-0261-6.","journal-title":"Behav Res Methods"},{"key":"3049_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11773-7","volume":"24","author":"MA Van Beers","year":"2024","unstructured":"Van Beers MA, Speksnijder CM, Van Gils CH, Frederix GWJ, Dankbaar JW, De Bree R. Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass (PECTORALIS): study protocol for a randomized controlled trial. BMC Cancer. 2024;24:76. https:\/\/doi.org\/10.1186\/s12885-023-11773-7.","journal-title":"BMC Cancer"},{"key":"3049_CR13","doi-asserted-by":"publisher","first-page":"e0294147","DOI":"10.1371\/journal.pone.0294147","volume":"18","author":"AWMA Schaeffers","year":"2023","unstructured":"Schaeffers AWMA, Devriese LA, Van Gils CH, Dankbaar JW, Voortman J, De Boer JP, et al. Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: the CISLOW-study protocol. PLOS One. 2023;18:e0294147. https:\/\/doi.org\/10.1371\/journal.pone.0294147.","journal-title":"PLOS One"},{"key":"3049_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/jamasurg.2023.0198","volume":"158","author":"CJL Molenaar","year":"2023","unstructured":"Molenaar CJL, Minnella EM, Coca-Martinez M, Ten Cate DWG, Regis M, Awasthi R, et al. Effect of multimodal prehabilitation on reducing postoperative complications and enhancing functional capacity following colorectal cancer surgery: the PREHAB randomized clinical trial. JAMA Surg. 2023;158:572. https:\/\/doi.org\/10.1001\/jamasurg.2023.0198.","journal-title":"JAMA Surg"},{"key":"3049_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40463-020-00486-7","volume":"50","author":"I Loewen","year":"2021","unstructured":"Loewen I, Jeffery CC, Rieger J, Constantinescu G. Prehabilitation in head and neck cancer patients: a literature review. J Otolaryngol Head Neck Surg. 2021;50:2. https:\/\/doi.org\/10.1186\/s40463-020-00486-7.","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"3049_CR16","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"3049_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA Hayden","year":"2013","unstructured":"Hayden JA, Van Der Windt DA, Cartwright JL, C\u00f4t\u00e9 P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158:280. https:\/\/doi.org\/10.7326\/0003-4819-158-4-201302190-00009.","journal-title":"Ann Intern Med"},{"key":"3049_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12:55\u201361. https:\/\/doi.org\/10.1002\/jrsm.1411.","journal-title":"Res Synth Methods"},{"key":"3049_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/1077559504264265","volume":"9","author":"L Geeraert","year":"2004","unstructured":"Geeraert L, Van Den Noortgate W, Grietens H, Onghena P. The effects of early prevention programs for families with young children at risk for physical child abuse and neglect: a meta-analysis. Child Maltreat. 2004;9:277\u201391. https:\/\/doi.org\/10.1177\/1077559504264265.","journal-title":"Child Maltreat"},{"key":"3049_CR20","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3758\/s13428-014-0527-2","volume":"47","author":"W Van Den Noortgate","year":"2015","unstructured":"Van Den Noortgate W, L\u00f3pez-L\u00f3pez JA, Mar\u00edn-Mart\u00ednez F, S\u00e1nchez-Meca J. Meta-analysis of multiple outcomes: a multilevel approach. Behav Res Methods. 2015;47:1274\u201394. https:\/\/doi.org\/10.3758\/s13428-014-0527-2.","journal-title":"Behav Res Methods"},{"key":"3049_CR21","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jamaoto.2017.0547","volume":"143","author":"V Achim","year":"2017","unstructured":"Achim V, Bash J, Mowery A, Guimaraes AR, Li R, Schindler J, et al. Prognostic indication of sarcopenia for wound complication after total laryngectomy. JAMA Otolaryngol Neck Surg. 2017;143:1159. https:\/\/doi.org\/10.1001\/jamaoto.2017.0547.","journal-title":"JAMA Otolaryngol Neck Surg"},{"key":"3049_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1017\/s0007114522000435","volume":"129","author":"E Ahern","year":"2023","unstructured":"Ahern E, Brown TE, Campbell L, Hughes BGM, Banks M, Lin CY, et al. Impact of sarcopenia and myosteatosis on survival outcomes for patients with head and neck cancer undergoing curative-intent treatment. Br J Nutr. 2023;129:406\u201315. https:\/\/doi.org\/10.1017\/s0007114522000435.","journal-title":"Br J Nutr"},{"key":"3049_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1055\/s-0040-1701696","volume":"36","author":"MM Alwani","year":"2020","unstructured":"Alwani MM, Jones AJ, Novinger LJ, Pittelkow E, Bonetto A, Sim MW, et al. Impact of sarcopenia on outcomes of autologous head and neck free tissue reconstruction. J Reconstr Microsurg. 2020;36:369\u201378. https:\/\/doi.org\/10.1055\/s-0040-1701696.","journal-title":"J Reconstr Microsurg"},{"key":"3049_CR24","doi-asserted-by":"publisher","first-page":"104530","DOI":"10.1016\/j.oraloncology.2019.104530","volume":"101","author":"E Ansari","year":"2020","unstructured":"Ansari E, Chargi N, Van Gemert JTM, Van Es RJJ, Dieleman FJ, Rosenberg AJWP, et al. Low skeletal muscle mass is a strong predictive factor for surgical complications and a prognostic factor in oral cancer patients undergoing mandibular reconstruction with a free fibula flap. Oral Oncol. 2020;101:104530. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.104530.","journal-title":"Oral Oncol"},{"key":"3049_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ijom.2022.02.008","volume":"51","author":"E Ansari","year":"2022","unstructured":"Ansari E, Chargi N, Van Es RJJ, Dieleman FJ, Van Cann EM, De Bree R. Association of preoperative low skeletal muscle mass with postoperative complications after selective neck dissection. Int J Oral Maxillofac Surg. 2022;51:1389\u201393. https:\/\/doi.org\/10.1016\/j.ijom.2022.02.008.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"3049_CR26","doi-asserted-by":"publisher","first-page":"699668","DOI":"10.3389\/fonc.2021.699668","volume":"11","author":"L Arribas","year":"2021","unstructured":"Arribas L, Plana M, Taberna M, Sospedra M, Vilari\u00f1o N, Oliva M, et al. Predictive value of skeletal muscle mass in recurrent\/metastatic head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors. Front Oncol. 2021;11:699668. https:\/\/doi.org\/10.3389\/fonc.2021.699668.","journal-title":"Front Oncol"},{"key":"3049_CR27","doi-asserted-by":"publisher","first-page":"994499","DOI":"10.3389\/fnut.2022.994499","volume":"9","author":"L Bardoscia","year":"2022","unstructured":"Bardoscia L, Besutti G, Pellegrini M, Pagano M, Bonelli C, Bonelli E, et al. Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation. Front Nutr. 2022;9:994499. https:\/\/doi.org\/10.3389\/fnut.2022.994499.","journal-title":"Front Nutr"},{"key":"3049_CR28","doi-asserted-by":"publisher","first-page":"e0282015","DOI":"10.1371\/journal.pone.0282015","volume":"18","author":"JN Becker","year":"2023","unstructured":"Becker JN, Hermann R, Wichmann J, Sonnhoff M, Christiansen H, Bruns F. Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy. PLOS One. 2023;18:e0282015. https:\/\/doi.org\/10.1371\/journal.pone.0282015.","journal-title":"PLOS One"},{"key":"3049_CR29","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1002\/cam4.5278","volume":"12","author":"R Bentahila","year":"2023","unstructured":"Bentahila R, Giraud P, Decazes P, Kreps S, Nay P, Chatain A, et al. The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapy. Cancer Med. 2023;12:4170\u201383. https:\/\/doi.org\/10.1002\/cam4.5278.","journal-title":"Cancer Med"},{"key":"3049_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcms.2023.01.014","volume":"51","author":"P Bonavolont\u00e0","year":"2023","unstructured":"Bonavolont\u00e0 P, Improta G, Dell\u2019Aversana Orabona G, Goglia F, Abbate V, Sorrentino A, et al. Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: a retrospective single-center study. J Cranio Maxillofac Surg. 2023;51:7\u201315. https:\/\/doi.org\/10.1016\/j.jcms.2023.01.014.","journal-title":"J Cranio Maxillofac Surg"},{"key":"3049_CR31","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/hed.25638","volume":"41","author":"SI Bril","year":"2019","unstructured":"Bril SI, Pezier TF, Tijink BM, Janssen LM, Braunius WW, De Bree R. Preoperative low skeletal muscle mass as a risk factor for pharyngocutaneous fistula and decreased overall survival in patients undergoing total laryngectomy. Head Neck. 2019;41:1745\u201355. https:\/\/doi.org\/10.1002\/hed.25638.","journal-title":"Head Neck"},{"key":"3049_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/hed.26919","volume":"44","author":"SI Bril","year":"2022","unstructured":"Bril SI, Al\u2010Mamgani A, Chargi N, Remeijer P, Devriese LA, De Boer JP, et al. The association of pretreatment low skeletal muscle mass with chemotherapy dose\u2010limiting toxicity in patients with head and neck cancer undergoing primary chemoradiotherapy with high\u2010dose cisplatin. Head Neck. 2022;44:189\u2013200. https:\/\/doi.org\/10.1002\/hed.26919.","journal-title":"Head Neck"},{"key":"3049_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00405-021-07127-3","volume":"279","author":"M Casasayas","year":"2022","unstructured":"Casasayas M, Garc\u00eda-Lorenzo J, G\u00f3mez-Ans\u00f3n B, Medina V, Fern\u00e1ndez A, Quer M, et al. Low skeletal muscle mass assessed directly from the 3rd cervical vertebra can predict pharyngocutaneous fistula risk after total laryngectomy in the male population. Eur Arch Otorhinolaryngol. 2022;279:853\u201363. https:\/\/doi.org\/10.1007\/s00405-021-07127-3.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3049_CR34","doi-asserted-by":"publisher","first-page":"E2257","DOI":"10.1002\/lary.29390","volume":"131","author":"S Chang","year":"2021","unstructured":"Chang S, Hsu C, Tsai Y, Chang G, Tsai M, Huang EI, et al. Prognostic value of third cervical vertebra skeletal muscle index in oral cavity cancer: a retrospective study. Laryngoscope. 2021;131:E2257\u2013E2265. https:\/\/doi.org\/10.1002\/lary.29390.","journal-title":"Laryngoscope"},{"key":"3049_CR35","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00405-019-05361-4","volume":"276","author":"N Chargi","year":"2019","unstructured":"Chargi N, Bril SI, Emmelot-Vonk MH, De Bree R. Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer. Eur Arch Otorhinolaryngol. 2019;276:1475\u201386. https:\/\/doi.org\/10.1007\/s00405-019-05361-4.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3049_CR36","doi-asserted-by":"publisher","first-page":"104519","DOI":"10.1016\/j.oraloncology.2019.104519","volume":"101","author":"N Chargi","year":"2020","unstructured":"Chargi N, Bril SI, Swartz JE, Wegner I, Willems SM, De Bree R. Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma. Oral Oncol. 2020;101:104519. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.104519.","journal-title":"Oral Oncol"},{"key":"3049_CR37","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1007\/s00405-021-07229-y","volume":"279","author":"N Chargi","year":"2022","unstructured":"Chargi N, Bashiri F, Wendrich AW, Smid EJ, De Jong PA, Huitema ADR, et al. Image-based analysis of skeletal muscle mass predicts cisplatin dose-limiting toxicity in patients with locally advanced head and neck cancer. Eur Arch Otorhinolaryngol. 2022;279:3685\u201394. https:\/\/doi.org\/10.1007\/s00405-021-07229-y.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3049_CR38","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1002\/hed.26310","volume":"42","author":"Y Choi","year":"2020","unstructured":"Choi Y, Ahn K, Jang J, Shin N, Jung S, Kim B, et al. Prognostic value of computed tomography\u2010based volumetric body composition analysis in patients with head and neck cancer: Feasibility study. Head Neck. 2020;42:2614\u201325. https:\/\/doi.org\/10.1002\/hed.26310.","journal-title":"Head Neck"},{"key":"3049_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2217\/bmm-2022-0748","volume":"17","author":"E Erul","year":"2023","unstructured":"Erul E, Guven DC, Ozbay Y, Altunbulak AY, Kahvecioglu A, Ercan F, et al. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma. Biomark Med. 2023;17:87\u201399. https:\/\/doi.org\/10.2217\/bmm-2022-0748.","journal-title":"Biomark Med"},{"key":"3049_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/jhn.12788","volume":"33","author":"M Findlay","year":"2020","unstructured":"Findlay M, Brown C, De Abreu Louren\u00e7o R, White K, Bauer J. Sarcopenia and myosteatosis in patients undergoing curative radiotherapy for head and neck cancer: Impact on survival, treatment completion, hospital admission and cost. J Hum Nutr Diet. 2020;33:811\u201321. https:\/\/doi.org\/10.1111\/jhn.12788.","journal-title":"J Hum Nutr Diet"},{"key":"3049_CR41","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/jcsm.12829","volume":"12","author":"M Findlay","year":"2021","unstructured":"Findlay M, White K, Brown C, Bauer JD. Nutritional status and skeletal muscle status in patients with head and neck cancer: impact on outcomes. J Cachexia Sarcopenia Muscle. 2021;12:2187\u201398. https:\/\/doi.org\/10.1002\/jcsm.12829.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3049_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/cancers14020347","volume":"14","author":"A Galli","year":"2022","unstructured":"Galli A, Colombo M, Prizio C, Carrara G, Lira Luce F, Paesano PL, et al. Skeletal muscle depletion and major postoperative complications in locally-advanced head and neck cancer: a comparison between ultrasound of rectus femoris muscle and neck cross-sectional imaging. Cancers. 2022;14:347. https:\/\/doi.org\/10.3390\/cancers14020347.","journal-title":"Cancers"},{"key":"3049_CR43","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.radonc.2019.04.023","volume":"137","author":"RG Ganju","year":"2019","unstructured":"Ganju RG, Morse R, Hoover A, TenNapel M, Lominska CE. The impact of sarcopenia on tolerance of radiation and outcome in patients with head and neck cancer receiving chemoradiation. Radiother Oncol. 2019;137:117\u201324. https:\/\/doi.org\/10.1016\/j.radonc.2019.04.023.","journal-title":"Radiother Oncol"},{"key":"3049_CR44","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jamaoncol.2015.6339","volume":"2","author":"AJ Grossberg","year":"2016","unstructured":"Grossberg AJ, Chamchod S, Fuller CD, Mohamed ASR, Heukelom J, Eichelberger H, et al. Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma. JAMA Oncol. 2016;2:782. https:\/\/doi.org\/10.1001\/jamaoncol.2015.6339.","journal-title":"JAMA Oncol"},{"key":"3049_CR45","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.3390\/cancers14225536","volume":"14","author":"E Haehl","year":"2022","unstructured":"Haehl E, Alvino L, R\u00fchle A, Zou J, Fabian A, Grosu AL, et al. Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation. Cancers. 2022;14:5536. https:\/\/doi.org\/10.3390\/cancers14225536.","journal-title":"Cancers"},{"key":"3049_CR46","doi-asserted-by":"publisher","first-page":"104771","DOI":"10.1016\/j.oraloncology.2020.104771","volume":"108","author":"WZ He","year":"2020","unstructured":"He WZ, Jiang C, Liu LL, Yin CX, Rong YM, Hu WM, et al. Association of body composition with survival and inflammatory responses in patients with non-metastatic nasopharyngeal cancer. Oral Oncol. 2020;108:104771. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.104771.","journal-title":"Oral Oncol"},{"key":"3049_CR47","doi-asserted-by":"publisher","first-page":"625534","DOI":"10.3389\/fonc.2021.625534","volume":"11","author":"X Hua","year":"2021","unstructured":"Hua X, Li WZ, Huang X, Wen W, Huang HY, Long ZQ, et al. Modeling sarcopenia to predict survival for patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy. Front Oncol. 2021;11:625534. https:\/\/doi.org\/10.3389\/fonc.2021.625534.","journal-title":"Front Oncol"},{"key":"3049_CR48","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1002\/cam4.2538","volume":"8","author":"X Huang","year":"2019","unstructured":"Huang X, Ma J, Li L, Zhu X. Severe muscle loss during radical chemoradiotherapy for non\u2010metastatic nasopharyngeal carcinoma predicts poor survival. Cancer Med. 2019;8:6604\u201313. https:\/\/doi.org\/10.1002\/cam4.2538.","journal-title":"Cancer Med"},{"key":"3049_CR49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.clnu.2020.05.020","volume":"40","author":"X Huang","year":"2021","unstructured":"Huang X, Lv LN, Zhao Y, Li L, Zhu XD. Is skeletal muscle loss associated with chemoradiotherapy toxicity in nasopharyngeal carcinoma patients? A prospective study. Clin Nutr. 2021;40:295\u2013302. https:\/\/doi.org\/10.1016\/j.clnu.2020.05.020.","journal-title":"Clin Nutr"},{"key":"3049_CR50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/cancers14030785","volume":"14","author":"CH Huang","year":"2022","unstructured":"Huang CH, Lue KH, Chen PR, Hsieh TC, Chou YF. Association between sarcopenia and immediate complications and mortality in patients with oral cavity squamous cell carcinoma undergoing surgery. Cancers. 2022;14:785. https:\/\/doi.org\/10.3390\/cancers14030785.","journal-title":"Cancers"},{"key":"3049_CR51","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s00405-020-05972-2","volume":"277","author":"LFJ Huiskamp","year":"2020","unstructured":"Huiskamp LFJ, Chargi N, Devriese LA, De Jong PA, De Bree R. The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy. Eur Arch Otorhinolaryngol. 2020;277:2847\u201358. https:\/\/doi.org\/10.1007\/s00405-020-05972-2.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3049_CR52","doi-asserted-by":"publisher","first-page":"e22463","DOI":"10.7759\/cureus.22463","volume":"14","author":"W Jin","year":"2022","unstructured":"Jin W, Rich B, Yechieli R, Freedman L, Samuels MA, Abramowitz M, et al. A single axial slice of the sternocleidomastoids and paravertebral muscles associated with worse local progression-free survival and severe toxicity in sarcopenic head and neck cancer patients undergoing radiotherapy. Cureus. 2022;14:e22463. https:\/\/doi.org\/10.7759\/cureus.22463.","journal-title":"Cureus"},{"key":"3049_CR53","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/lio2.530","volume":"6","author":"AJ Jones","year":"2021","unstructured":"Jones AJ, Campiti VJ, Alwani M, Novinger LJ, Tucker BJ, Bonetto A, et al. Sarcopenia is associated with blood transfusions in head and neck cancer free flap surgery. Laryngoscope Investig Otolaryngol. 2021;6:200\u201310. https:\/\/doi.org\/10.1002\/lio2.530.","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"3049_CR54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.oraloncology.2019.06.009","volume":"95","author":"AR Jung","year":"2019","unstructured":"Jung AR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer. Oral Oncol. 2019;95:95\u20139. https:\/\/doi.org\/10.1016\/j.oraloncology.2019.06.009.","journal-title":"Oral Oncol"},{"key":"3049_CR55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejca.2019.05.006","volume":"116","author":"AR Jung","year":"2019","unstructured":"Jung AR, Roh JL, Kim JS, Kim SB, Choi SH, Nam SY, et al. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer. Eur J Cancer. 2019;116:98\u2013106. https:\/\/doi.org\/10.1016\/j.ejca.2019.05.006.","journal-title":"Eur J Cancer"},{"key":"3049_CR56","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jgo.2020.06.009","volume":"12","author":"AhR Jung","year":"2021","unstructured":"Jung AhR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. The impact of skeletal muscle depletion on older adult patients with head and neck cancer undergoing primary surgery. J Geriatr Oncol. 2021;12:128\u201333. https:\/\/doi.org\/10.1016\/j.jgo.2020.06.009.","journal-title":"J Geriatr Oncol"},{"key":"3049_CR57","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1002\/hed.25938","volume":"41","author":"RT Karsten","year":"2019","unstructured":"Karsten RT, Al\u2010Mamgani A, Bril SI, Tjon\u2010A\u2010Joe S, Van Der Molen L, De Boer JP, et al. Sarcopenia, a strong determinant for prolonged feeding tube dependency after chemoradiotherapy for head and neck cancer. Head Neck. 2019;41:4000\u20138. https:\/\/doi.org\/10.1002\/hed.25938.","journal-title":"Head Neck"},{"key":"3049_CR58","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1002\/lary.29221","volume":"131","author":"J Lee","year":"2021","unstructured":"Lee J, Liu S, Dai K, Huang Y, Li C, Chen JC, et al. Sarcopenia and systemic inflammation synergistically impact survival in oral cavity cancer. Laryngoscope. 2021;131:E1530\u2013E1538. https:\/\/doi.org\/10.1002\/lary.29221.","journal-title":"Laryngoscope"},{"key":"3049_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99201-3","volume":"11","author":"B Lee","year":"2021","unstructured":"Lee B, Bae YJ, Jeong WJ, Kim H, Choi BS, Kim JH. Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma. Sci Rep. 2021;11:19717. https:\/\/doi.org\/10.1038\/s41598-021-99201-3.","journal-title":"Sci Rep"},{"key":"3049_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.radonc.2021.02.014","volume":"158","author":"J Lee","year":"2021","unstructured":"Lee J, Liu SH, Chen JCH, Leu YS, Liu CJ, Chen YJ. Progressive muscle loss is an independent predictor for survival in locally advanced oral cavity cancer: a longitudinal study. Radiother Oncol. 2021;158:83\u20139. https:\/\/doi.org\/10.1016\/j.radonc.2021.02.014.","journal-title":"Radiother Oncol"},{"key":"3049_CR61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/coa.13481","volume":"45","author":"S Lin","year":"2020","unstructured":"Lin S, Lin Y, Kang B, Yin C, Chang K, Chi C, et al. Sarcopenia results in poor survival rates in oral cavity cancer patients. Clin Otolaryngol. 2020;45:327\u201333. https:\/\/doi.org\/10.1111\/coa.13481.","journal-title":"Clin Otolaryngol"},{"key":"3049_CR62","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/micr.30494","volume":"39","author":"T Makiguchi","year":"2019","unstructured":"Makiguchi T, Yamaguchi T, Nakamura H, Suzuki K, Harimoto N, Shirabe K, et al. Impact of skeletal muscle mass volume on surgical site infection in free flap reconstruction for oral cancer. Microsurgery. 2019;39:598\u2013604. https:\/\/doi.org\/10.1002\/micr.30494.","journal-title":"Microsurgery"},{"key":"3049_CR63","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/hed.26978","volume":"44","author":"MA Mascarella","year":"2022","unstructured":"Mascarella MA, Patel T, Vendra V, Gardiner L, Kergoat M, Kubik MW, et al. Poor treatment tolerance in head and neck cancer patients with low muscle mass. Head Neck. 2022;44:844\u201350. https:\/\/doi.org\/10.1002\/hed.26978.","journal-title":"Head Neck"},{"key":"3049_CR64","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/micr.30848","volume":"42","author":"MA Mascarella","year":"2022","unstructured":"Mascarella MA, Gardiner L, Patel T, Vendra V, Khan N, Kergoat M, et al. Cervical paraspinal skeletal muscle index outperforms frailty indices to predict postoperative adverse events in operable head and neck cancer with microvascular reconstruction. Microsurgery. 2022;42:209\u201316. https:\/\/doi.org\/10.1002\/micr.30848.","journal-title":"Microsurgery"},{"key":"3049_CR65","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.bjoms.2021.07.020","volume":"60","author":"DM McGoldrick","year":"2022","unstructured":"McGoldrick DM, Yassin Alsabbagh A, Shaikh M, Pettit L, Bhatia SK. Masseter muscle defined sarcopenia and survival in head and neck cancer patients. Br J Oral Maxillofac Surg. 2022;60:454\u20138. https:\/\/doi.org\/10.1016\/j.bjoms.2021.07.020.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"3049_CR66","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.3390\/cancers14092094","volume":"114","author":"R Morse","year":"2022","unstructured":"Morse R, Ganju RG, Gan GN, Cao Y, Neupane P, Kakarala K, et al. Sarcopenia and treatment toxicity in older adults undergoing chemoradiation for head and neck cancer: identifying factors to predict frailty. Int J Radiat Oncol. 2022;114:e295. https:\/\/doi.org\/10.3390\/cancers14092094.","journal-title":"Int J Radiat Oncol"},{"key":"3049_CR67","doi-asserted-by":"publisher","first-page":"105483","DOI":"10.1016\/j.oraloncology.2021.105483","volume":"121","author":"P Nagpal","year":"2021","unstructured":"Nagpal P, Pruthi DS, Pandey M, Yadav A, Singh H. Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: an Indian tertiary care hospital experience. Oral Oncol. 2021;121:105483. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105483.","journal-title":"Oral Oncol"},{"key":"3049_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000485515","volume":"80","author":"D Nishikawa","year":"2018","unstructured":"Nishikawa D, Hanai N, Suzuki H, Koide Y, Beppu S, Hasegawa Y. The impact of skeletal muscle depletion on head and neck squamous cell carcinoma. ORL. 2018;80:1\u20139. https:\/\/doi.org\/10.1159\/000485515.","journal-title":"ORL"},{"key":"3049_CR69","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/cam4.1365","volume":"7","author":"PC Pai","year":"2018","unstructured":"Pai PC, Chuang CC, Chuang WC, Tsang NM, Tseng CK, Chen KH, et al. Pretreatment subcutaneous adipose tissue predicts the outcomes of patients with head and neck cancer receiving definitive radiation and chemoradiation in Taiwan. Cancer Med. 2018;7:1630\u201341. https:\/\/doi.org\/10.1002\/cam4.1365.","journal-title":"Cancer Med"},{"key":"3049_CR70","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.radonc.2020.03.014","volume":"147","author":"MI Van Rijn-Dekker","year":"2020","unstructured":"Van Rijn-Dekker MI, Van Den Bosch L, Van Den Hoek JGM, Bijl HP, Van Aken ESM, Van Der Hoorn A, et al. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy. Radiother Oncol. 2020;147:103\u201310. https:\/\/doi.org\/10.1016\/j.radonc.2020.03.014.","journal-title":"Radiother Oncol"},{"key":"3049_CR71","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00405-020-06273-4","volume":"278","author":"R Shodo","year":"2021","unstructured":"Shodo R, Yamazaki K, Ueki Y, Takahashi T, Horii A. Sarcopenia predicts a poor treatment outcome in patients with head and neck squamous cell carcinoma receiving concurrent chemoradiotherapy. Eur Arch Otorhinolaryngol. 2021;278:2001\u20139. https:\/\/doi.org\/10.1007\/s00405-020-06273-4.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3049_CR72","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/jamaoto.2019.1185","volume":"145","author":"L Stone","year":"2019","unstructured":"Stone L, Olson B, Mowery A, Krasnow S, Jiang A, Li R, et al. Association between sarcopenia and mortality in patients undergoing surgical excision of head and neck cancer. JAMA Otolaryngol Neck Surg. 2019;145:647. https:\/\/doi.org\/10.1001\/jamaoto.2019.1185.","journal-title":"JAMA Otolaryngol Neck Surg"},{"key":"3049_CR73","doi-asserted-by":"publisher","first-page":"106018","DOI":"10.1016\/j.oraloncology.2022.106018","volume":"132","author":"Y Takenaka","year":"2022","unstructured":"Takenaka Y, Takemoto N, Otsuka T, Nishio M, Tanida M, Fujii T, et al. Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: a multicenter retrospective study. Oral Oncol. 2022;132:106018. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.106018.","journal-title":"Oral Oncol"},{"key":"3049_CR74","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/0194599818793857","volume":"160","author":"A Tamaki","year":"2019","unstructured":"Tamaki A, Manzoor NF, Babajanian E, Ascha M, Rezaee R, Zender CA. Clinical significance of sarcopenia among patients with advanced oropharyngeal cancer. Otolaryngol Neck Surg. 2019;160:480\u20137. https:\/\/doi.org\/10.1177\/0194599818793857.","journal-title":"Otolaryngol Neck Surg"},{"key":"3049_CR75","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/cancers13040753","volume":"13","author":"S Thureau","year":"2021","unstructured":"Thureau S, Lebret L, Lequesne J, Cabourg M, Dandoy S, Gouley C, et al. Prospective evaluation of sarcopenia in head and neck cancer patients treated with radiotherapy or radiochemotherapy. Cancers. 2021;13:753. https:\/\/doi.org\/10.3390\/cancers13040753.","journal-title":"Cancers"},{"key":"3049_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.21037\/qims-21-43","volume":"12","author":"HC Van Heusden","year":"2022","unstructured":"Van Heusden HC, Chargi N, Dankbaar JW, Smid EJ, De Bree R. Masseter muscle parameters can function as an alternative for skeletal muscle mass assessments on cross-sectional imaging at lumbar or cervical vertebral levels. Quant Imaging Med Surg. 2022;12:15\u201327. https:\/\/doi.org\/10.21037\/qims-21-43.","journal-title":"Quant Imaging Med Surg"},{"key":"3049_CR77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.oraloncology.2017.05.012","volume":"71","author":"AW Wendrich","year":"2017","unstructured":"Wendrich AW, Swartz JE, Bril SI, Wegner I, De Graeff A, Smid EJ, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. Oral Oncol. 2017;71:26\u201333. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.05.012.","journal-title":"Oral Oncol"},{"key":"3049_CR78","doi-asserted-by":"publisher","first-page":"7699","DOI":"10.1002\/cam4.5522","volume":"12","author":"ACH Willemsen","year":"2023","unstructured":"Willemsen ACH, De Moor N, Van Dessel J, Baijens LWJ, Bila M, Hauben E, et al. The predictive and prognostic value of weight loss and body composition prior to and during immune checkpoint inhibition in recurrent or metastatic head and neck cancer patients. Cancer Med. 2023;12:7699\u2013712. https:\/\/doi.org\/10.1002\/cam4.5522.","journal-title":"Cancer Med"},{"key":"3049_CR79","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.21037\/atm-21-3412","volume":"9","author":"X Xing","year":"2021","unstructured":"Xing X, Zhou X, Yang Y, Li Y, Hu C, Shen C. The impact of body composition parameters on severe toxicities in patients with locoregionally advanced nasopharyngeal carcinoma undergoing neoadjuvant chemotherapy. Ann Transl Med. 2021;9:1180\u20131180. https:\/\/doi.org\/10.21037\/atm-21-3412.","journal-title":"Ann Transl Med"},{"key":"3049_CR80","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.anl.2021.03.021","volume":"48","author":"K Yamahara","year":"2021","unstructured":"Yamahara K, Mizukoshi A, Lee K, Ikegami S. Sarcopenia with inflammation as a predictor of survival in patients with head and neck cancer. Auris Nasus Larynx. 2021;48:1013\u201322. https:\/\/doi.org\/10.1016\/j.anl.2021.03.021.","journal-title":"Auris Nasus Larynx"},{"key":"3049_CR81","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.3390\/cancers12113167","volume":"12","author":"T Yoshimura","year":"2020","unstructured":"Yoshimura T, Suzuki H, Takayama H, Higashi S, Hirano Y, Tezuka M, et al. Impact of preoperative low prognostic nutritional index and high intramuscular adipose tissue content on outcomes of patients with oral squamous cell carcinoma. Cancers. 2020;12:3167. https:\/\/doi.org\/10.3390\/cancers12113167.","journal-title":"Cancers"},{"key":"3049_CR82","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s00405-021-07147-z","volume":"279","author":"D Yunaiyama","year":"2022","unstructured":"Yunaiyama D, Okubo M, Arizono E, Tsukahara K, Tanigawa M, Nagao T, et al. Sarcopenia at the infrahyoid level as a prognostic factor in patients with advanced-stage non-virus-related head and neck carcinoma. Eur Arch Otorhinolaryngol. 2022;279:3131\u20137. https:\/\/doi.org\/10.1007\/s00405-021-07147-z.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"3049_CR83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.oraloncology.2016.09.006","volume":"62","author":"JE Swartz","year":"2016","unstructured":"Swartz JE, Pothen AJ, Wegner I, Smid EJ, Swart KMA, De Bree R, et al. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol. 2016;62:28\u201333. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.09.006.","journal-title":"Oral Oncol"},{"key":"3049_CR84","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1067\/mlc.2001.113504","volume":"137","author":"JE Morley","year":"2001","unstructured":"Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137:231\u201343. https:\/\/doi.org\/10.1067\/mlc.2001.113504.","journal-title":"J Lab Clin Med"},{"key":"3049_CR85","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ebiom.2019.10.034","volume":"49","author":"C Nelke","year":"2019","unstructured":"Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. eBioMedicine. 2019;49:381\u20138. https:\/\/doi.org\/10.1016\/j.ebiom.2019.10.034.","journal-title":"eBioMedicine"},{"key":"3049_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17987\/jcsm-cr.v3i2.65","volume":"3","author":"CL Cole","year":"2018","unstructured":"Cole CL, Kleckner IR, Jatoi A, Schwarz EM, Dunne RF. The role of systemic inflammation in cancer\u2010associated muscle wasting and rationale for exercise as a therapeutic intervention. JCSM Clin Rep. 2018;3:1\u201319.","journal-title":"JCSM Clin Rep"},{"key":"3049_CR87","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00520-007-0388-7","volume":"16","author":"I Bosaeus","year":"2008","unstructured":"Bosaeus I. Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer. 2008;16:447\u201351. https:\/\/doi.org\/10.1007\/s00520-007-0388-7.","journal-title":"Support Care Cancer"},{"key":"3049_CR88","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s00520-021-06633-8","volume":"30","author":"C Capit\u00e3o","year":"2022","unstructured":"Capit\u00e3o C, Coutinho D, Neves PM, Capelas ML, Pimenta NM, Santos T, et al. Protein intake and muscle mass maintenance in patients with cancer types with high prevalence of sarcopenia: a systematic review. Support Care Cancer. 2022;30:3007\u201315. https:\/\/doi.org\/10.1007\/s00520-021-06633-8.","journal-title":"Support Care Cancer"},{"key":"3049_CR89","doi-asserted-by":"publisher","first-page":"79884","DOI":"10.18632\/oncotarget.20168","volume":"8","author":"the PreMiO Study Group","year":"2017","unstructured":"the PreMiO Study Group, Muscaritoli M, Lucia S, Farcomeni A, Lorusso V, Saracino V, et al. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget. 2017;8:79884\u201396. https:\/\/doi.org\/10.18632\/oncotarget.20168.","journal-title":"Oncotarget"},{"key":"3049_CR90","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","volume":"13","author":"F Petermann\u2010Rocha","year":"2022","unstructured":"Petermann\u2010Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta\u2010analysis. J Cachexia Sarcopenia Muscle. 2022;13:86\u201399. https:\/\/doi.org\/10.1002\/jcsm.12783.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3049_CR91","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejca.2015.12.030","volume":"57","author":"SS Shachar","year":"2016","unstructured":"Shachar SS, Williams GR, Muss HB, Nishijima TF. Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review. Eur J Cancer. 2016;57:58\u201367. https:\/\/doi.org\/10.1016\/j.ejca.2015.12.030.","journal-title":"Eur J Cancer"},{"key":"3049_CR92","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1634\/theoncologist.2016-0066","volume":"21","author":"HN Rier","year":"2016","unstructured":"Rier HN, Jager A, Sleijfer S, Maier AB, Levin MD. The prevalence and prognostic value of low muscle mass in cancer patients: a review of the literature. Oncologist. 2016;21:1396\u2013409. https:\/\/doi.org\/10.1634\/theoncologist.2016-0066.","journal-title":"Oncologist"},{"key":"3049_CR93","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jcsm.12268","volume":"9","author":"F Buckinx","year":"2018","unstructured":"Buckinx F, Landi F, Cesari M, Fielding RA, Visser M, Engelke K, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018;9:269\u201378. https:\/\/doi.org\/10.1002\/jcsm.12268.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3049_CR94","doi-asserted-by":"publisher","first-page":"109879","DOI":"10.1016\/j.ejrad.2021.109879","volume":"142","author":"HC Van Heusden","year":"2021","unstructured":"Van Heusden HC, Swartz JE, Chargi N, De Jong PA, Van Baal MCPM, Wegner I, et al. Feasibility of assessment of skeletal muscle mass on a single cross-sectional image at the level of the fourth thoracic vertebra. Eur J Radio. 2021;142:109879. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109879.","journal-title":"Eur J Radio"},{"key":"3049_CR95","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jcsm.12158","volume":"8","author":"JLA Van Vugt","year":"2017","unstructured":"Van Vugt JLA, Levolger S, Gharbharan A, Koek M, Niessen WJ, Burger JWA, et al. A comparative study of software programmes for cross\u2010sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients. J Cachexia Sarcopenia Muscle. 2017;8:285\u201397. https:\/\/doi.org\/10.1002\/jcsm.12158.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3049_CR96","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00330-020-07440-1","volume":"50","author":"AT Zwart","year":"2023","unstructured":"Zwart AT, Cavalheiro VJ, Lamers MJ, Dierckx RAJO, De Bock GH, Halmos GB, et al. The validation of low-dose CT scans from the [18F]-FDG PET-CT scan to assess skeletal muscle mass in comparison with diagnostic neck CT scans. Eur J Nucl Med Mol Imaging. 2023;50:1735\u201342. https:\/\/doi.org\/10.1007\/s00330-020-07440-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3049_CR97","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1007\/s00259-023-06117-3","volume":"31","author":"AT Zwart","year":"2021","unstructured":"Zwart AT, Becker JN, Lamers MJ, Dierckx RAJO, De Bock GH, Halmos GB, et al. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed. Eur Radio. 2021;31:4053\u201362. https:\/\/doi.org\/10.1007\/s00259-023-06117-3.","journal-title":"Eur Radio"},{"key":"3049_CR98","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/s1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:629\u201335. https:\/\/doi.org\/10.1016\/s1470-2045(08)70153-0.","journal-title":"Lancet Oncol"},{"key":"3049_CR99","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/jco.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539\u201347. https:\/\/doi.org\/10.1200\/jco.2012.45.2722.","journal-title":"J Clin Oncol"},{"key":"3049_CR100","doi-asserted-by":"publisher","first-page":"e2328280","DOI":"10.1001\/jamanetworkopen.2023.28280","volume":"6","author":"Z Ye","year":"2023","unstructured":"Ye Z, Saraf A, Ravipati Y, Hoebers F, Catalano PJ, Zha Y, et al. Development and validation of an automated image-based deep learning platform for sarcopenia assessment in head and neck cancer. JAMA Netw Open. 2023;6:e2328280. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.28280.","journal-title":"JAMA Netw Open"},{"key":"3049_CR101","doi-asserted-by":"publisher","first-page":"930432","DOI":"10.3389\/fonc.2022.930432","volume":"12","author":"MA Naser","year":"2022","unstructured":"Naser MA, Wahid KA, Grossberg AJ, Olson B, Jain R, El-Habashy D, et al. Deep learning auto-segmentation of cervical skeletal muscle for sarcopenia analysis in patients with head and neck cancer. Front Oncol. 2022;12:930432. https:\/\/doi.org\/10.3389\/fonc.2022.930432.","journal-title":"Front Oncol"},{"key":"3049_CR102","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3389\/fonc.2019.01561","volume":"9","author":"X Hua","year":"2020","unstructured":"Hua X, Liu S, Liao JF, Wen W, Long ZQ, Lu ZJ, et al. When the loss costs too much: a systematic review and meta-analysis of sarcopenia in head and neck cancer. Front Oncol. 2020;9:1561. https:\/\/doi.org\/10.3389\/fonc.2019.01561.","journal-title":"Front Oncol"},{"key":"3049_CR103","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jand.2020.03.021","volume":"120","author":"M Findlay","year":"2020","unstructured":"Findlay M, White K, Lai M, Luo D, Bauer JD. The association between computed tomography\u2013defined sarcopenia and outcomes in adult patients undergoing radiotherapy of curative intent for head and neck cancer: a systematic review. J Acad Nutr Diet. 2020;120:1330\u2013.e8. https:\/\/doi.org\/10.1016\/j.jand.2020.03.021.","journal-title":"J Acad Nutr Diet"},{"key":"3049_CR104","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.clnu.2020.09.017","volume":"40","author":"M Findlay","year":"2021","unstructured":"Findlay M, White K, Stapleton N, Bauer J. Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis. Clin Nutr. 2021;40:1711\u20138. https:\/\/doi.org\/10.1016\/j.clnu.2020.09.017.","journal-title":"Clin Nutr"},{"key":"3049_CR105","doi-asserted-by":"publisher","first-page":"e0259288","DOI":"10.1371\/journal.pone.0259288","volume":"16","author":"Y Takenaka","year":"2021","unstructured":"Takenaka Y, Takemoto N, Oya R, Inohara H. Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: a meta-analysis. PLOS ONE. 2021;16:e0259288. https:\/\/doi.org\/10.1371\/journal.pone.0259288. Birkeland A, editor","journal-title":"PLOS ONE"},{"key":"3049_CR106","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/lary.28616","volume":"131","author":"A Wong","year":"2021","unstructured":"Wong A, Zhu D, Kraus D, Tham T. Radiologically defined sarcopenia affects survival in head and neck cancer: a meta\u2010analysis. Laryngoscope. 2021;131:333\u201341. https:\/\/doi.org\/10.1002\/lary.28616.","journal-title":"Laryngoscope"},{"key":"3049_CR107","doi-asserted-by":"publisher","first-page":"175883592110088","DOI":"10.1177\/17588359211008844","volume":"13","author":"A Surov","year":"2021","unstructured":"Surov A, Wienke A. Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis. Ther Adv Med Oncol. 2021;13:175883592110088. https:\/\/doi.org\/10.1177\/17588359211008844.","journal-title":"Ther Adv Med Oncol"},{"key":"3049_CR108","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/advances\/nmac076","volume":"13","author":"A Edwards","year":"2022","unstructured":"Edwards A, Hughes BGM, Brown T, Bauer J. Prevalence and impact of computed tomography\u2013defined sarcopenia on survival in patients with human papillomavirus\u2013positive oropharyngeal cancer: a systematic review. Adv Nutr. 2022;13:2433\u201344. https:\/\/doi.org\/10.1093\/advances\/nmac076.","journal-title":"Adv Nutr"},{"key":"3049_CR109","doi-asserted-by":"publisher","first-page":"106608","DOI":"10.1016\/j.oraloncology.2023.106608","volume":"147","author":"JP Graves","year":"2023","unstructured":"Graves JP, Daher GS, Bauman MMJ, Moore EJ, Tasche KK, Price DL, et al. Association of sarcopenia with oncologic outcomes of primary treatment among patients with oral cavity cancer: a systematic review and meta-analysis. Oral Oncol. 2023;147:106608. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106608.","journal-title":"Oral Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03049-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03049-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03049-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:43:07Z","timestamp":1781847787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03049-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8,10]]}},"alternative-id":["3049"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03049-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"10 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}